Leadership, Planning and Evaluation

领导、规划和评估

• 批准号: 10627035
• 负责人: ROBERT S. MANNEL
• 金额: $ 18.86万
• 依托单位: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-01 至 2028-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10627035
• 关键词: Address; Appointment; Basic Science; Cancer Center; Cancer Center Support Grant; Catchment Area; Clinical; Clinical Cancer Center; Clinical Research; Collaborations; Communication; Communities; Community Outreach; Component of the Center for Cancer Research; Data; Decision Making; Development; Diabetes Mellitus; Doctor of Philosophy; Education; Effectiveness; Ensure; Evaluation; Evaluation Research; Faculty; Fostering; Funding; Geroscience; Goals; Leadership; Malignant Neoplasms; Mentorship; Minority Groups; Minority Women; Mission; NCI Center for Cancer Research; Oklahoma; Outcome; Persons; Play; Policies; Positioning Attribute; Process; Productivity; Publications; Reporting; Research; Research Activity; Resource Allocation; Resource Sharing; Role; Science; Strategic Planning; Students; Training; Translational Research; Translations; Underrepresented Minority; Update; cancer research center director; cancer risk; career; community engagement; community setting; design; equity, diversity, and inclusion; experience; improved outcome; meetings; operation; programs

LEADERSHIP, PLANNING AND EVALUATION: ABSTRACT The Stephenson Cancer Center (SCC) conducts formal planning and evaluation activities, under the oversight of the SCC director and senior leadership team, to advance its mission of eliminating cancer in Oklahoma (SCC catchment area) and beyond. Planning and evaluation are critically important for a matrix cancer center like the SCC to ensure optimal coordination, integration, and effectiveness of SCC activities and resource allocation. The following core strategic priorities inform the goals, tactics, and metrics for all SCC research components: 1) enhancing breadth, depth, and impact of cancer-focused research; 2) fostering the translation of discoveries into the clinical or community setting; 3) designing and conducting hypothesis-driven trials to improve outcomes for people with or at risk for cancer; 4) promoting intra- and inter-programmatic collaboration and transdisciplinary team science; 5) enhancing COE to address priority cancers and cancer problems prevalent in the SCC catchment area; 6) increasing training and mentorship opportunities for students and faculty; and 7) enhancing the presence of underrepresented minority persons and women among SCC leadership and membership, and in pipeline programs. For oversight, planning, and evaluation of research activities, SCC Director Robert Mannel, MD has assembled an experienced senior leadership team of associate directors (ADs) who oversee the following functions: basic research (Danny Dhanasekaran, PhD); translational research (Priyabrata Mukherjee, PhD); clinical research (Kathleen Moore, MD); community outreach and engagement (Mark Doescher, MD); education, training, and career enhancement (Rajagopal Ramesh, PhD); diversity, equity, and inclusion (Joan Walker, MD); and research administration (Wade Williams, PhD). Since Mannel’s appointment as SCC director in 2006, strategic planning and evaluation has played a central role in the development of the SCC. The standing Research Leadership Committee (RLC) and Research Steering Committee (RSC), which are comprised of leaders for all research components at the SCC, provide regular forums for planning and evaluating progress. In addition, research leadership is well represented in SCC clinical planning and evaluation. External input from scientific and community advisory boards augment these planning and evaluation activities. New strategic initiatives emerging from planning discussions during the reporting period include: research program realignment (2018); strategic partnerships with the Oklahoma Center for Geroscience (2018) and Harold Hamm Diabetes Center (2019); new initiatives to enhance SCC research focused on catchment area priority cancers and prevalent cancer problems (2019); increased engagement with OU Norman to foster cancer-focused research and collaborations (2020); establishing a new AD position for diversity, equity, and inclusion, and broad planning for how to enhance DEI among SCC leadership and membership, and in pipeline education programs (2021).

领导，计划和评估：摘要 斯蒂芬森癌症中心（SCC）在监督下进行正式的计划和评估活动 SCC主任和高级领导团队的任务是消除俄克拉荷马州的癌症的使命 （SCC集水区）​​及以后。计划和评估对于基质癌症中心至关重要 像SCC一样，以确保SCC活动和资源的最佳协调，集成和有效性 分配。以下核心战略优先事项为所有SCC研究提供了目标，策略和指标 组件：1）增强以癌症为中心的研究的广度，深度和影响； 2）培养翻译 进入临床或社区环境的发现； 3）设计和进行假设驱动的试验 改善患有癌症或有癌症风险的人的预后； 4）促进组织内和编程间协作 和跨学科团队科学； 5）增强COE解决优先癌和癌症问题 在SCC集水区中流行； 6）增加学生的培训和指导机会 学院; 7）在SCC中增强了代表性不足的少数族裔和妇女的存在 领导力和会员资格，以及管道计划。进行研究，计划和评估 活动，SCC主管Robert Mannel，医学博士已组建了一个经验丰富的高级领导团队 监督以下功能的副董事（ADS）：基础研究（Danny Dhanasekaran，PhD）； 翻译研究（Priyabrata Mukherjee，PhD）；临床研究（马里兰州凯瑟琳·摩尔）；社区 宣传与参与（马克·杜彻（Mark Docher），马里兰州）；教育，培训和职业增强（Rajagopal Ramesh，博士）；多样性，公平和包容性（马里兰州琼·沃克）；和研究管理局（韦德 威廉姆斯，博士）。 自从Mannel于2006年任命为SCC董事以来，战略规划和评估已发挥了中心作用 在SCC的发展中的作用。常设研究领导委员会（RLC）和研究 指导委员会（RSC）已完成SCC的所有研究组件的领导者 定期计划和评估进度的论坛。此外，研究领导力得到很好的代表 SCC临床计划和评估。科学和社区咨询委员会的外部投入 这些计划和评估活动。从计划讨论中提出的新战略举措 报告期包括：研究计划重组（2018年）；与俄克拉荷马州的战略伙伴关系 Geroscience中心（2018年）和Harold Hamm糖尿病中心（2019年）；增强SCC的新计划 研究重点是集水区优先级癌症和普遍的癌症问题（2019年）；增加 与OU Norman订婚以促进以癌症为中心的研究和合作（2020年）；建立新的 多样性，公平和包容性的广告地位，以及如何在SCC中增强DEI的广泛计划 领导力和会员资格，以及管道教育计划（2021）。